Neuren Pharmaceuticals LimitedCompany Review & Valuation

OTC Markets

About Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited, a biopharmaceutical company, engages in the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its lead product is Trofinetide, which is in Phase II clinical trials for use in the treatment of Rett syndrome, Fragile X syndromShow moree, moderate to severe traumatic brain injury, and concussion. The company is also developing NNZ-2591 that is in preclinical development for the treatment of various neurological disorders. In addition, it holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Auckland, New Zealand.Show less

HQ Location
Auckland, New Zealand

Stock Price

Price data not available for Neuren Pharmaceuticals Limited.


Please login or create a free account to view the contents of this section.

Similar Companies

ACADIA Pharmaceuticals

back to top